Cryosite (CTE) Stock Price, News & Analysis

Company Overview

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological, as well as logistics services to the clinical trials, research, and pharmaceutical industries. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 418 shs
• Average Volume: N/A
• Market Capitalization: A$36.36 million
• P/E Ratio: 19.76
• Dividend Yield: 9.40%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: ASX:CTE
• CIK: N/A
• Web: www.cryosite.com
• Phone: 61 2 8865 2000
• Fax: N/A
• Employees: 25
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A$0.04
• Trailing P/E Ratio: 19.76
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: A$1.84 million
• Net Margins: 14.59%
• Pretax Margin: N/A
• Return on Equity: 84.70%
• Return on Assets: 6.06%

Debt

• Debt-to-Equity Ratio: 168.74
• Current Ratio: 1.94
• Quick Ratio: 1.76

Sales & Book Value

• Annual Sales: A$12.61 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.55
• Book Value: A$0.03 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 48,810,000
• Free Float: N/A
• Market Cap: A$36.36 million
• Optionable: Not Optionable
• Beta: 0.40